Camp4 Therapeutics (CAMP) Interest Expenses (2023 - 2026)
Camp4 Therapeutics (CAMP) reported Interest Expenses of $56000.0 for Q1 2026, down 95.07% on a YoY basis from $1.1 million in Q1 2025, and down 93.61% sequentially from $876000.0 in Q4 2025.
Camp4 Therapeutics (CAMP) Interest Expenses (2023 - 2026) Analysis & Trends
Camp4 Therapeutics (CAMP) has 4 years of Interest Expenses data on file, last reported at $56000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses fell 95.07% year-over-year to $56000.0; the trailing twelve-month figure through Mar 2026 stood at $2.9 million (down 21.62% YoY), and the FY2025 full-year result was $76.1 million, up 17.28% from the prior year.
- Interest Expenses retreated to $56000.0 in Q1 2026, from $876000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $10.4 million in Q3 2024 to a low of $56000.0 in Q1 2026.
- A 4-year average of $2.2 million and a median of $876000.0 in 2025 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses jumped 1271.26% in 2024 and sank 95.07% in 2026, its largest moves.
- Tracing CAMP's Interest Expenses over 4 years: stood at $464000.0 in 2023, then surged by 86.85% to $867000.0 in 2024, then rose by 1.04% to $876000.0 in 2025, then tumbled by 93.61% to $56000.0 in 2026.
- Business Quant data shows CAMP's Interest Expenses at $56000.0 in Q1 2026, $876000.0 in Q4 2025, and $876000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 32.89 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 16.81 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.17 Bn |
| 10 | Camp4 Therapeutics | 174.35 Mn | 174.35 Mn | - | 56,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 56,000.00 |
| Mar 31, 2026 | 56,000.00 |
| Dec 31, 2025 | 876,000.00 |
| Dec 31, 2025 | 876,000.00 |
| Sep 30, 2025 | 876,000.00 |
| Sep 30, 2025 | 876,000.00 |
| Jun 30, 2025 | 7.55 Mn |
| Jun 30, 2025 | 7.55 Mn |
| Mar 31, 2025 | 1.14 Mn |
| Mar 31, 2025 | 1.14 Mn |
| Dec 31, 2024 | 867,000.00 |
| Dec 31, 2024 | 867,000.00 |
| Sep 30, 2024 | 10.35 Mn |
| Sep 30, 2024 | 10.35 Mn |
| Jun 30, 2024 | 650,000.00 |
| Jun 30, 2024 | 650,000.00 |
| Mar 31, 2024 | 1.10 Mn |
| Mar 31, 2024 | 1.10 Mn |
| Dec 31, 2023 | 464,000.00 |
| Dec 31, 2023 | 464,000.00 |